Lista de obras - Frank G. Schaap - Dominio Público Uruguay

A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia

artículo científico publicado en 2006

Accuracy of prediction scores and novel biomarkers for predicting nonalcoholic fatty liver disease in obese children

artículo científico publicado en 2013

Alterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery

artículo científico publicado en 2011

ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis

artículo científico publicado en 2004

Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study

artículo científico publicado en 2006

Apolipoprotein A5 deficiency aggravates high-fat diet-induced obesity due to impaired central regulation of food intake

artículo científico publicado en 2013

Apolipoprotein AV does not contribute to hypertriglyceridaemia or triglyceride lowering by dietary fish oil and rosiglitazone in obese Zucker rats

artículo científico publicado en 2006

Bile acid receptors as targets for drug development.

artículo científico

Bile acids drive the newborn's gut microbiota maturation

scientific article published on 23 July 2020

Bile salts predict liver regeneration in rabbit model of portal vein embolization ⬇️

artículo científico publicado el 27 de junio de 2012

Calorie restriction and Roux-en-Y gastric bypass have opposing effects on circulating FGF21 in morbidly obese subjects

scientific article published on 12 June 2014

Can plasma bile salt, triglycerides, and apoA-V levels predict liver regeneration?

artículo científico publicado en 2012

Cathepsin D regulates lipid metabolism in murine steatohepatitis

artículo científico publicado en 2017

Changes in Hepatic ApoAV Expression are not Required for the Rapid Triglyceride Lowering Effect of Fish Oil Diet in Rats

artículo científico publicado en 2008

Cholangiocarcinoma, gone without the Wnt?

artículo científico publicado en 2016

Cholic acid therapy in Zellweger spectrum disorders.

artículo científico publicado en 2016

Chronic elevation of plasma fibroblast growth factor 19 in long-term farnesoid X receptor agonist therapy, a happy marriage or cause for oncological concern?

artículo científico publicado en 2017

Diosgenin-induced biliary cholesterol secretion in mice requires Abcg8.

artículo científico publicado en 2005

Effect of Plasmapheresis on Cholestatic Pruritus and Autotaxin Activity During Pregnancy

scientific article published on 14 February 2019

Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health

artículo científico publicado en 2012

Effect of wheat bran derived prebiotic supplementation on gastrointestinal transit, gut microbiota, and metabolic health: a randomized controlled trial in healthy adults with a slow gut transit

scientific article published on 25 January 2020

Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding

artículo científico publicado en 2008

Efficient lowering of triglyceride levels in mice by human apoAV protein variants associated with hypertriglyceridemia

artículo científico publicado en 2009

Elevated interleukin-8 in bile of patients with primary sclerosing cholangitis.

artículo científico publicado en 2016

Estrogen induced hypertriglyceridemia in an apolipoprotein AV deficient patient.

artículo científico publicado en 2008

Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia

artículo científico publicado en 2006

Evolution of the family of intracellular lipid binding proteins in vertebrates

artículo científico publicado en 2002

FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis

artículo científico publicado en 2018

FXR, intestinal FiXeR of hepatocellular carcinoma?

artículo científico publicado en 2014

Fatty acid-binding proteins in the heart

artículo científico publicado el 1 de marzo de 1998

Fibroblast growth factor 19, an anticholestatic drug produced by human liver

artículo científico publicado en 2012

Fibroblast growth factor 21 is induced by endoplasmic reticulum stress

scientific journal article

Gallbladder Dyskinesia Is Associated With an Impaired Postprandial Fibroblast Growth Factor 19 Response in Critically Ill Patients

scientific article published on 05 June 2019

Gut microbes take it to the next level? First insights into FXR agonists of microbial origin

artículo científico publicado en 2020

Hepatocyte nuclear factor-4alpha regulates the human apolipoprotein AV gene: identification of a novel response element and involvement in the control by peroxisome proliferator-activated receptor-gamma coactivator-1alpha, AMP-activated protein kina

artículo científico publicado en 2005

High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis

artículo científico publicado en 2009

How sweet it is to activate FXR

artículo científico publicado en 2014

Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene

artículo científico publicado en 2008

Impact of global Fxr deficiency on experimental acute pancreatitis and genetic variation in the FXR locus in human acute pancreatitis

artículo científico publicado en 2014

Interactions between bile salts, gut microbiota, and hepatic innate immunity.

artículo científico publicado en 2017

Intestinal failure to produce FGF19: A culprit in intestinal failure-associated liver disease?

artículo científico publicado en 2015

Low circulating concentrations of citrulline and FGF19 predict chronic cholestasis and poor survival in adult patients with chronic intestinal failure: development of a Model for End-Stage Intestinal Failure (MESIF risk score)

scientific article published on 01 June 2019

Molecular cloning of fatty acid-transport protein cDNA from rat

scientific journal article

Mutations in the Isocitrate Dehydrogenase Genes IDH1 and IDH2 in Tumors ⬇️

artículo científico publicado el 1 de enero de 2013

One-step purification of rat heart-type fatty acid-binding protein expressed in Escherichia coli.

artículo científico publicado en 1996

Pandora's box opens for cholestatic liver disease

scientific article published on 12 January 2016

Pharmacological activation of the bile acid nuclear farnesoid X receptor is feasible in patients with quiescent Crohn's colitis.

artículo científico publicado en 2012

Pituitary TSH controls bile salt synthesis

artículo científico publicado en 2015

Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism

artículo científico publicado en 2006

Plasma apolipoprotein AV levels in mice are positively associated with plasma triglyceride levels.

artículo científico publicado en 2009

Prevention and reversal of hepatic steatosis with a high-protein diet in mice.

artículo científico publicado en 2013

Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge

scientific article published on 30 September 2016

Prometheus' little helper, a novel role for fibroblast growth factor 15 in compensatory liver growth

artículo científico publicado en 2013

Relation between hepatic expression of ATP-binding cassette transporters G5 and G8 and biliary cholesterol secretion in mice

artículo científico publicado en 2003

Role of fibroblast growth factor 19 in the control of glucose homeostasis.

artículo científico

Serum Autotaxin Activity Correlates With Pruritus in Pediatric Cholestatic Disorders

artículo científico publicado en 2016

Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions.

artículo científico publicado en 2012

Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype

artículo científico publicado en 2014

The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance.

artículo científico publicado en 2010

The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract.

artículo científico publicado en 2011

The influence of chemotherapy-associated sinusoidal dilatation on short-term outcome after partial hepatectomy for colorectal liver metastases: A systematic review with meta-analysis.

artículo científico publicado en 2016

The role of bile salts in liver regeneration

artículo científico publicado en 2016

Thyroid hormone regulates the hypotriglyceridemic gene APOA5

scientific journal article

Validation of the peak bilirubin criterion for outcome after partial hepatectomy.

artículo científico publicado en 2016

Yin Yang 1 and farnesoid X receptor: a balancing act in non-alcoholic fatty liver disease?

scientific article published on 08 March 2013

Lista de obras de Frank G. Schaap

A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia

Accuracy of prediction scores and novel biomarkers for predicting nonalcoholic fatty liver disease in obese children

Alterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery

ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis

Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study

Apolipoprotein A5 deficiency aggravates high-fat diet-induced obesity due to impaired central regulation of food intake

Apolipoprotein AV does not contribute to hypertriglyceridaemia or triglyceride lowering by dietary fish oil and rosiglitazone in obese Zucker rats

Bile acid receptors as targets for drug development.

Bile acids drive the newborn's gut microbiota maturation

Bile salts predict liver regeneration in rabbit model of portal vein embolization ⬇️

Calorie restriction and Roux-en-Y gastric bypass have opposing effects on circulating FGF21 in morbidly obese subjects

Can plasma bile salt, triglycerides, and apoA-V levels predict liver regeneration?

Cathepsin D regulates lipid metabolism in murine steatohepatitis

Changes in Hepatic ApoAV Expression are not Required for the Rapid Triglyceride Lowering Effect of Fish Oil Diet in Rats

Cholangiocarcinoma, gone without the Wnt?

Cholic acid therapy in Zellweger spectrum disorders.

Chronic elevation of plasma fibroblast growth factor 19 in long-term farnesoid X receptor agonist therapy, a happy marriage or cause for oncological concern?

Diosgenin-induced biliary cholesterol secretion in mice requires Abcg8.

Effect of Plasmapheresis on Cholestatic Pruritus and Autotaxin Activity During Pregnancy

Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health

Effect of wheat bran derived prebiotic supplementation on gastrointestinal transit, gut microbiota, and metabolic health: a randomized controlled trial in healthy adults with a slow gut transit

Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding

Efficient lowering of triglyceride levels in mice by human apoAV protein variants associated with hypertriglyceridemia

Elevated interleukin-8 in bile of patients with primary sclerosing cholangitis.

Estrogen induced hypertriglyceridemia in an apolipoprotein AV deficient patient.

Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia

Evolution of the family of intracellular lipid binding proteins in vertebrates

FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis

FXR, intestinal FiXeR of hepatocellular carcinoma?

Fatty acid-binding proteins in the heart

Fibroblast growth factor 19, an anticholestatic drug produced by human liver

Fibroblast growth factor 21 is induced by endoplasmic reticulum stress

Gallbladder Dyskinesia Is Associated With an Impaired Postprandial Fibroblast Growth Factor 19 Response in Critically Ill Patients

Gut microbes take it to the next level? First insights into FXR agonists of microbial origin

Hepatocyte nuclear factor-4alpha regulates the human apolipoprotein AV gene: identification of a novel response element and involvement in the control by peroxisome proliferator-activated receptor-gamma coactivator-1alpha, AMP-activated protein kina

High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis

How sweet it is to activate FXR

Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene

Impact of global Fxr deficiency on experimental acute pancreatitis and genetic variation in the FXR locus in human acute pancreatitis

Interactions between bile salts, gut microbiota, and hepatic innate immunity.

Intestinal failure to produce FGF19: A culprit in intestinal failure-associated liver disease?

Low circulating concentrations of citrulline and FGF19 predict chronic cholestasis and poor survival in adult patients with chronic intestinal failure: development of a Model for End-Stage Intestinal Failure (MESIF risk score)

Molecular cloning of fatty acid-transport protein cDNA from rat

Mutations in the Isocitrate Dehydrogenase Genes IDH1 and IDH2 in Tumors ⬇️

One-step purification of rat heart-type fatty acid-binding protein expressed in Escherichia coli.

Pandora's box opens for cholestatic liver disease

Pharmacological activation of the bile acid nuclear farnesoid X receptor is feasible in patients with quiescent Crohn's colitis.

Pituitary TSH controls bile salt synthesis

Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism

Plasma apolipoprotein AV levels in mice are positively associated with plasma triglyceride levels.

Prevention and reversal of hepatic steatosis with a high-protein diet in mice.

Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge

Prometheus' little helper, a novel role for fibroblast growth factor 15 in compensatory liver growth

Relation between hepatic expression of ATP-binding cassette transporters G5 and G8 and biliary cholesterol secretion in mice

Role of fibroblast growth factor 19 in the control of glucose homeostasis.

Serum Autotaxin Activity Correlates With Pruritus in Pediatric Cholestatic Disorders

Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions.

Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype

The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance.

The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract.

The influence of chemotherapy-associated sinusoidal dilatation on short-term outcome after partial hepatectomy for colorectal liver metastases: A systematic review with meta-analysis.

The role of bile salts in liver regeneration

Thyroid hormone regulates the hypotriglyceridemic gene APOA5

Validation of the peak bilirubin criterion for outcome after partial hepatectomy.

Yin Yang 1 and farnesoid X receptor: a balancing act in non-alcoholic fatty liver disease?